Antibodies Market: Autoimmune Disorders Indication Segment is Expected to Expand at The Highest CAGR Health Articles | August 24 [url=http://www.cheapjerseyssuns.com/steve-nash-jersey/]Cheap Steve Nash Jersey[/url] , 2016

Future Market Insights has announced the addition of the “Antibodies Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.

High rate of product approvals, combined with rising adoption of therapeutic antibodies in developing economies is positively influencing the growth of the聽global antibodies market, with total revenues expected to surpass US$ 105 Bn in 2016. Approval of monoclonal antibody products, including therapeutic antibodies, drug conjugates [url=http://www.cheapjerseyssuns.com/dan-majerle-jersey/]Cheap Dan Majerle Jersey[/url] , and antibody fragments in key markets of the U.S., Europe, and Japan have bolstered the growth of the global antibodies market. Availability of inexpensive biosimilar antibody therapeutics is also bolstering the growth of the antibody market.

While the short- and long-term outlook on the global antibodies market remains positive, side effects associated with antibody treatment and failure of investigational drugs in late stages of development can pose challenges to widespread adoption. Administration of antibodies has been linked to serum sickness and acute anaphylaxis, posing challenges to widespread adoption.

By drug type [url=http://www.cheapjerseyssuns.com/kevin-johnson-jersey/]Cheap Kevin Johnson Jersey[/url] , monoclonal antibodies will continue to dominate demand, accounting for nearly 95% share of the market in 2016. Of the US$ 105 Bn worth of antibodies therapeutics expected to be sold in 2016, monoclonal antibodies will account for US$ 99.81 Bn. Polyclonal antibodies and antibody-drug complexes will represent minority share of the global market.

Request for sample report:

Hospitals will remain the largest end-users in the global antibodies market, accounting for over 85% revenue share in 2016. Demand for antibodies from hospitals end-use segment will witness a year-over-year growth rate of over 12% and surpass US$ 90 Bn in revenues.

By disease indication, the key segments of the global antibodies market include CNS disorders [url=http://www.cheapjerseyssuns.com/penny-hardaway-jersey/]Cheap Penny Hardaway Jersey[/url] , cardiovascular diseases, cancer, and autoimmune disorders. Cancer remains the most prominent indication segment, accounting for nearly 54% revenue share in 2016. Cardiovascular diseases is the smallest segment in the global antibodies market in terms of revenues, and will witness the lowest growth rates among all the indication segments.

North America will continue to remain the largest market in the global antibodies market [url=http://www.cheapjerseyssuns.com/]Wholesale Phoenix Suns Jerseys[/url] , accounting for nearly 44% revenue share of the market in 2016. In the U.S. therapeutic antibody products are subject to submission of biologics licence application (BLA), whereas in Canada, Biologics and Genetic Therapies Directorate (BGTD) governs the approval of biological products. The U.S. accounts for the majority revenue share of the North America antibodies market, and will witness a higher growth rate than Canada.

In addition to North America, Western Europe and APEJ will continue to remain the other top markets for antibodies. While the U.K. [url=http://www.cheapjerseyssuns.com/]Wholesale Suns Jerseys[/url] , Germany, and France will remain the top 3 markets in Western Europe, demand for antibodies in APEJ will remain largely concentrated in China, India, and ASEAN.

Request for TOC:

Hoffmann-La Roche AG [url=http://www.cheapjerseyssuns.com/]Cheap Phoenix Suns Jerseys[/url] , AbbVie Inc., and Johnson & Johnson will maintain their position as the top 3 players in the global antibodies market. These 3 players collectively account for nearly 57% revenue share of the global antibodies market. Herceptin, Avastin (Roche), Humira (AbbVie), and Remicade (J&J) are the blockbuster drugs in the global antibodies market. Other key players in the market are Amgen Inc. [url=http://www.cheapjerseyssuns.com/]Cheap Suns Jerseys[/url] , Bristol-Myers Squibb Company, Biogen Inc., Merck & Co, and Novartis. Gaining product approvals from EU and FDA and strengthening collaborations with distribution partners remains a key strategy for leading players in the global antibodies market.

Long-term Outlook:聽The global antibodies market is expected to increase at a CAGR of 12.5% during the forecast period 2016-2026 and surpass US$ 341 Bn in revenues.

Cardiovascular Surgical Devices and Technologies Market 2016: Global Industry Review, Research [url=http://www.cheapjerseyssuns.com/dragan-bender-jersey/]Wholesale Dragan Bender Jersey[/url] , Stat Marketing Articles | August 4, 2016

Global Market Research Report on Cardiovascular Surgical Devices and Technologies Market 2016 is a professional and in-depth complete study on the current state of the Cardiovascular Surgical Devices and Technologies worldwide.

Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed, namely closed and open types of surgeries. The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013. Increase in incidence for heart related problems are mainly due to changes in life style. This life style changes has increased the rate of heart surgeries. The U.S. is the leading market for cardiovascular surgical devices due to increase in aging population that is suffering from cardiovascular problems.

The growth of Cardiovascular surgical devices market was hampered by efficient alternative technologies such as percutaneous coronary intervention (PCI) techniques and other minimal invasive techniques (Ablation techniques); moreover [url=http://www.cheapjerseyssuns.com/brandan-wright-jersey/]Wholesale Brandan Wright Jersey[/url] , shortage of skilled surgeons and high cost of surgical procedures are hindering the growth of cardiovascular surgical device market in developing countries. Lower success rate of heart related surgeries in minimal invasive techniques is reducing the growth of cardiovascular surgical device market in developing economies.

Get Free Sample Report Of Cardiovascular surgical devi. [url=http://wholesaleauthenticjerseysnba.com/]http://wholesaleauthenticjerseysnba.com/[/url]   [url=http://wholesaleauthenticjerseyscollege.com/]Wholesale Jerseys[/url]   [url=http://cheapauthenticjerseysnba.com/]Cheap NBA Jerseys Free Shipping[/url]   [url=http://cheapauthenticjerseyscollege.com/]Cheap College Basketball Jerseys[/url]   [url=http://www.cheapreplicasoccerjerseyschina.com/]Cheap Soccer Jerseys China[/url]   [url=http://www.cheapnikenbajerseyswholesale.com/]Cheap Authentic NBA Jerseys[/url]   [url=http://www.cheapreplicamlbjerseys.com/]Wholesale Jerseys[/url]   [url=http://www.cheapnikesoccerjerseys.com/]Cheap Retro Soccer Jerseys[/url]   [url=http://www.cheapnikenfljerseys.com/]Cheap Football Jerseys China[/url]   [url=http://www.cheapnhlreplicajerseys.com/]Wholesale Authentic NHL Jerseys[/url]